The reported weight loss represents uniform drug concentration, identical injection devices, and thousands of data points collected under identical conditions
Both Hengrui Pharmas ribupatide and Innovents higher-dose mazdutide have reported phase 3 trial data suggesting greater weight-loss efficacy than semaglutide
Even modest sustained weight loss of 510% provides meaningful health benefits, including improved glycemic control, reduced cardiovascular risk factors, and decreased joint stress
Choosing the right syringe matters too
If you have type 2 diabetes and take other glucose-lowering medications, discuss hypoglycemia risk and whether medication adjustments are needed
While there is a known genetic risk component to pancreatitis, its generally caused by lifestyle choices, as a consequence of other conditions (like gallstones), or from prescription medications like GLP-1s